White & Case was named "Cross-Border M&A Law Firm of the Year" at The M&A Advisor's 8th Annual International M&A Awards ceremony on April 12. The Firm also scooped the award for "Cross-Border Healthcare and Life Sciences M&A Deal of the Year" for advising CVC Capital Partners in leading a consortium that acquired a controlling stake in generic pharmaceuticals company Alvogen.
The Annual International M&A Awards recognize the top international deals, dealmakers and firms conducting important transactions in the Americas, Europe, Asia, the Middle East, Africa and Australia. From among 250 finalists, a panel of 19 independent judges chosen for their international industry expertise selected the winners.
These awards follow Bloomberg's first-quarter M&A league table results, which placed White & Case as Number 1 for cross-border M&A by value, having advised on 45 announced deals with an aggregate value of more than US$139 billion.